• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肯尼亚优化艾滋病毒耐药性检测实验室网络:系统工程建模的见解。

Optimising HIV drug resistance testing laboratory networks in Kenya: insights from systems engineering modelling.

机构信息

Department of Industrial & Systems Engineering, University of Washington, Seattle, Washington, USA

National HIV Reference Laboratory, Kenya Ministry of Health, Nairobi, Kenya.

出版信息

BMJ Open. 2024 Apr 3;14(4):e079988. doi: 10.1136/bmjopen-2023-079988.

DOI:10.1136/bmjopen-2023-079988
PMID:38569688
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11146353/
Abstract

BACKGROUND

HIV drug resistance (DR) is a growing threat to the durability of current and future HIV treatment success. DR testing (DRT) technologies are very expensive and specialised, relying on centralised laboratories in most low and middle-income countries. Modelling for laboratory network with point-of-care (POC) DRT assays to minimise turnaround time (TAT), is urgently needed to meet the growing demand.

METHODS

We developed a model with user-friendly interface using integer programming and queueing theory to improve the DRT system in Kisumu County, Kenya. We estimated DRT demand based on both current and idealised scenarios and evaluated a centralised laboratory-only network and an optimised POC DRT network. A one-way sensitivity analysis of key user inputs was conducted.

RESULTS

In a centralised laboratory-only network, the mean TAT ranged from 8.52 to 8.55 working days, and the system could not handle a demand proportion exceeding 1.6%. In contrast, the mean TAT for POC DRT network ranged from 1.13 to 2.11 working days, with demand proportion up to 4.8%. Sensitivity analyses showed that expanding DRT hubs reduces mean TAT substantially while increasing the processing rate at national labs had minimal effect. For instance, doubling the current service rate at national labs reduced the mean TAT by only 0.0%-1.9% in various tested scenarios, whereas doubling the current service rate at DRT hubs reduced the mean TAT by 37.5%-49.8%. In addition, faster batching modes and transportation were important factors influencing the mean TAT.

CONCLUSIONS

Our model offers decision-makers an informed framework for improving the DRT system using POC in Kenya. POC DRT networks substantially reduce mean TAT and can handle a higher demand proportion than a centralised laboratory-only network, especially for children and pregnant women living with HIV, where there is an immediate push to use DRT results for patient case management.

摘要

背景

艾滋病毒耐药性(DR)对当前和未来艾滋病毒治疗成功的持久性构成日益严重的威胁。耐药性检测(DRT)技术非常昂贵且专业化,大多数中低收入国家依赖于中央实验室。为了满足日益增长的需求,迫切需要建立一个实验室网络模型,使用即时检测(POC)DRT 检测来最小化周转时间(TAT)。

方法

我们使用整数规划和排队论开发了一个具有用户友好界面的模型,以改善肯尼亚基苏木县的 DRT 系统。我们根据当前和理想的情况估计了 DRT 的需求,并评估了一个集中式实验室网络和一个优化的 POC DRT 网络。对关键用户输入进行了单向敏感性分析。

结果

在集中式实验室网络中,平均 TAT 范围为 8.52 至 8.55 个工作日,系统无法处理超过 1.6%的需求比例。相比之下,POC DRT 网络的平均 TAT 范围为 1.13 至 2.11 个工作日,需求比例高达 4.8%。敏感性分析表明,扩大 DRT 中心可以大大缩短平均 TAT,同时增加国家实验室的处理率对 TAT 的影响最小。例如,在各种测试场景中,将国家实验室目前的服务率提高一倍仅将平均 TAT 降低 0.0%至 1.9%,而将 DRT 中心目前的服务率提高一倍将平均 TAT 降低 37.5%至 49.8%。此外,更快的批量处理模式和运输方式是影响平均 TAT 的重要因素。

结论

我们的模型为决策者提供了一个框架,用于使用肯尼亚的即时检测来改进 DRT 系统。POC DRT 网络可大大缩短平均 TAT,并且可以处理比集中式实验室网络更高的需求比例,特别是对于儿童和艾滋病毒感染孕妇,他们立即需要使用 DRT 结果进行患者病例管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7339/11146353/12c50498e14e/bmjopen-2023-079988f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7339/11146353/bb01458e7731/bmjopen-2023-079988f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7339/11146353/12c50498e14e/bmjopen-2023-079988f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7339/11146353/bb01458e7731/bmjopen-2023-079988f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7339/11146353/12c50498e14e/bmjopen-2023-079988f02.jpg

相似文献

1
Optimising HIV drug resistance testing laboratory networks in Kenya: insights from systems engineering modelling.肯尼亚优化艾滋病毒耐药性检测实验室网络:系统工程建模的见解。
BMJ Open. 2024 Apr 3;14(4):e079988. doi: 10.1136/bmjopen-2023-079988.
2
Using queueing models as a decision support tool in allocating point-of-care HIV viral load testing machines in Kisumu County, Kenya.利用排队模型作为决策支持工具,在肯尼亚基苏木县分配即时 HIV 病毒载量检测机。
Health Policy Plan. 2024 Jan 9;39(1):44-55. doi: 10.1093/heapol/czad111.
3
"After viral load testing, I get my results so I get to know which path my life is taking me": qualitative insights on routine centralized and point-of-care viral load testing in western Kenya from the Opt4Kids and Opt4Mamas studies.“进行病毒载量检测后,我拿到了结果,从而了解到我的人生将走向何方”:肯尼亚西部 Opt4Kids 和 Opt4Mamas 研究中关于常规集中式和即时病毒载量检测的定性见解。
BMC Health Serv Res. 2022 Dec 17;22(1):1540. doi: 10.1186/s12913-022-08593-z.
4
HIV Drug Resistance Patterns and Characteristics Associated with Clinically Significant Drug Resistance among Children with Virologic Failure on Antiretroviral Treatment in Kenya: Findings from the Opt4Kids Randomized Controlled Trial.肯尼亚接受抗逆转录病毒治疗后病毒学失败的儿童中与临床显著耐药性相关的 HIV 耐药模式和特征:Opt4Kids 随机对照试验的结果。
Viruses. 2023 Oct 12;15(10):2083. doi: 10.3390/v15102083.
5
Cost-effectiveness of point-of-care versus centralised, laboratory-based nucleic acid testing for diagnosis of HIV in infants: a systematic review of modelling studies.即时检测与集中式实验室核酸检测诊断婴儿 HIV 的成本效益:系统评价模型研究。
Lancet HIV. 2023 May;10(5):e320-e331. doi: 10.1016/S2352-3018(23)00029-2.
6
An integrated tiered service delivery model (ITSDM) based on local CD4 testing demands can improve turn-around times and save costs whilst ensuring accessible and scalable CD4 services across a national programme.基于当地CD4检测需求的综合分层服务提供模式(ITSDM)可以缩短周转时间并节省成本,同时确保在全国范围内的项目中提供可及且可扩展的CD4服务。
PLoS One. 2014 Dec 9;9(12):e114727. doi: 10.1371/journal.pone.0114727. eCollection 2014.
7
Evaluation of near point-of-care viral load implementation in public health facilities across seven countries in sub-Saharan Africa.撒哈拉以南非洲七个国家公共卫生机构即时检测病毒载量实施情况评估。
J Int AIDS Soc. 2021 Jan;24(1):e25663. doi: 10.1002/jia2.25663.
8
Impact of point-of-care HIV viral load and targeted drug resistance mutation testing on viral suppression among Kenyan pregnant and postpartum women: results from a prospective cohort study (Opt4Mamas).肯尼亚孕妇和产后妇女中即时 HIV 病毒载量和靶向耐药突变检测对病毒抑制的影响:一项前瞻性队列研究的结果(Opt4Mamas)。
J Int AIDS Soc. 2023 Nov;26(11):e26182. doi: 10.1002/jia2.26182.
9
Evaluation of a routine point-of-care intervention for early infant diagnosis of HIV: an observational study in eight African countries.评估常规即时护理干预措施对婴儿艾滋病早期诊断的效果:在八个非洲国家开展的观察性研究。
Lancet HIV. 2019 Jun;6(6):e373-e381. doi: 10.1016/S2352-3018(19)30033-5. Epub 2019 Apr 12.
10
Estimating implementation and operational costs of an integrated tiered CD4 service including laboratory and point of care testing in a remote health district in South Africa.估算南非一个偏远卫生区综合分层CD4服务(包括实验室检测和即时检测)的实施和运营成本。
PLoS One. 2014 Dec 17;9(12):e115420. doi: 10.1371/journal.pone.0115420. eCollection 2014.

本文引用的文献

1
More Frequent HIV Viral Load Testing With Point-Of-Care Tests Detects Elevated Viral Load Earlier in Postpartum HIV-Positive Women in a Randomized Controlled Trial in Two Clinics in Johannesburg, South Africa.在南非约翰内斯堡的两家诊所进行的一项随机对照试验中,使用即时检测的更频繁 HIV 病毒载量检测可更早地发现产后 HIV 阳性女性的病毒载量升高。
J Acquir Immune Defic Syndr. 2023 Dec 15;94(5):412-420. doi: 10.1097/QAI.0000000000003295.
2
Using queueing models as a decision support tool in allocating point-of-care HIV viral load testing machines in Kisumu County, Kenya.利用排队模型作为决策支持工具,在肯尼亚基苏木县分配即时 HIV 病毒载量检测机。
Health Policy Plan. 2024 Jan 9;39(1):44-55. doi: 10.1093/heapol/czad111.
3
Need assessment for HIV drug resistance testing and landscape of current and future technologies in low- and middle-income countries.
低收入和中等收入国家艾滋病毒耐药性检测的需求评估以及当前和未来技术的概况
PLOS Glob Public Health. 2023 Oct 18;3(10):e0001948. doi: 10.1371/journal.pgph.0001948. eCollection 2023.
4
HIV-1 drug resistance in people on dolutegravir-based antiretroviral therapy: a collaborative cohort analysis.基于多替拉韦的抗逆转录病毒治疗患者中的 HIV-1 耐药性:一项协作队列分析。
Lancet HIV. 2023 Nov;10(11):e733-e741. doi: 10.1016/S2352-3018(23)00228-X. Epub 2023 Oct 10.
5
"I feel drug resistance testing allowed us to make an informed decision": qualitative insights on the role of HIV drug resistance mutation testing among children and pregnant women living with HIV in western Kenya.“我觉得耐药性检测让我们能够做出明智的决定”:肯尼亚西部 HIV 阳性儿童和孕妇对 HIV 耐药突变检测作用的定性研究
BMC Health Serv Res. 2023 Aug 24;23(1):908. doi: 10.1186/s12913-023-09804-x.
6
Increasing the initiation of antiretroviral therapy through optimal placement of diagnostic technologies for pediatric HIV in Zimbabwe: A modeling analysis.通过在津巴布韦优化儿科艾滋病诊断技术的定位来增加抗逆转录病毒疗法的启动:建模分析。
Int J Infect Dis. 2023 Sep;134:31-38. doi: 10.1016/j.ijid.2023.05.013. Epub 2023 May 16.
7
HIV-1 integrase resistance associated mutations and the use of dolutegravir in Sub-Saharan Africa: A systematic review and meta-analysis.人类免疫缺陷病毒1型整合酶耐药相关突变及多替拉韦在撒哈拉以南非洲地区的应用:一项系统评价与荟萃分析
PLOS Glob Public Health. 2022 Oct 11;2(10):e0000826. doi: 10.1371/journal.pgph.0000826. eCollection 2022.
8
Implementation of an interactive mobile application to pilot a rapid assay to detect HIV drug resistance mutations in Kenya.在肯尼亚实施一款交互式移动应用程序,以试点一项用于检测艾滋病毒耐药性突变的快速检测方法。
PLOS Glob Public Health. 2022 Feb 16;2(2):e0000185. doi: 10.1371/journal.pgph.0000185. eCollection 2022.
9
"After viral load testing, I get my results so I get to know which path my life is taking me": qualitative insights on routine centralized and point-of-care viral load testing in western Kenya from the Opt4Kids and Opt4Mamas studies.“进行病毒载量检测后,我拿到了结果,从而了解到我的人生将走向何方”:肯尼亚西部 Opt4Kids 和 Opt4Mamas 研究中关于常规集中式和即时病毒载量检测的定性见解。
BMC Health Serv Res. 2022 Dec 17;22(1):1540. doi: 10.1186/s12913-022-08593-z.
10
Point-of-care HIV viral load and targeted drug resistance mutation testing versus standard care for Kenyan children on antiretroviral therapy (Opt4Kids): an open-label, randomised controlled trial.基于护理点的 HIV 病毒载量和靶向耐药突变检测与肯尼亚抗逆转录病毒治疗儿童的标准护理相比(Opt4Kids):一项开放标签、随机对照试验。
Lancet Child Adolesc Health. 2022 Oct;6(10):681-691. doi: 10.1016/S2352-4642(22)00191-2. Epub 2022 Aug 18.